| 1. |
Zimmet, P., Alberti, K. G. M. M., and Shaw, J. (2001) Global and societal implications of the diabetes epidemic. Nature
414, 782–787.
|
| |
| 2. |
Gloyn, A. L. and McCarthy, M. I. (2001) The genetics of type 2 diabetes. Best Pract. Res. Clin. Endocrinol. Metab.
15, 293–308.
|
| |
| 3. |
Stride, A. and Hattersley, A. T. (2002) Different genes, different diabetes: lessons from maturity-onset diabetes of the young.
Ann. Med.
23, 207–216.
|
| |
| 4. |
McCarthy, M. I. (2004) Progress in defining the molecular basis of type 2 diabetes through susceptibility gene identification.
Hum. Mol. Genet.
13, R33–R41.
|
| |
| 5. |
Ioannidis, J. P. A., Ntzani, E. E., Trikalinos, T. A., and Contopoulos-Ioannidis, J. G. (2001) Replication validity of genetic
association studies. Nat. Genet.
29, 306–309.
|
| |
| 6. |
Ioannidis, J. P. A., Trikalinos, T. A, and Ntzani, E. E., Contopoulos-Ioannidis, J. G. (2003) Genetic associations in large
versus small studies: an empirical assessment. Lancet
361, 567–571.
|
| |
| 7. |
Hattersley, A. T. and McCarthy, M. I. (2005) A question of standards: what makes a good genetic association study? Lancet
366, 1315–1323.
|
| |
| 8. |
Wacholder, S., Chanock, S., Garcia-Closas, M., El Ghormli, L., and Rothman, N. (2004). Assessing the probability that a positive
report is false: an approach for molecular epidemiology studies. J. Natl. Cancer Inst.
96, 434–442.
|
| |
| 9. |
Glazier, A. M., Nadeau, J. H., and Aitman, T. J. (2002) Finding genes that underlie complex traits. Science
298, 2345–2349.
|
| |
| 10. |
Love-Gregory, L., Wasson, J., Ma, J., et al. (2004) A common polymorphism in the upstream promoter region of the hepatocyte
nuclear factor-4 gene on chromosome 20q is associated with type 2 diabetes and appears to contribute to the evidence for linkage
in an Ashkenazi Jewish population. Diabetes
53, 1134–1140.
|
| |
| 11. |
Silander, K., Mohlke, K. L., Scott, L. J., et al. (2004) Genetic variation near the hepatocyte nuclear factor-4 gene predicts
susceptibility to type 2 diabetes. Diabetes
53, 1141–1149.
|
| |
| 12. |
Weedon, M. N., Owen, K. R., Shields, B., et al. (2004) Common variants of the hepatocyte nuclear factor-4alpha P2 promoter
are associated with type 2 diabetes in the UK population. Diabetes
53, 3002–3006.
|
| |
| 13. |
Weedon, M. N., Frayling, T. M., Shields, B., et al. (2005) Genetic regulation of birth weight and fasting glucose by a common
polymorphism in the islet cell promoter of the glucokinase gene. Diabetes
54, 576–581.
|
| |
| 14. |
Altshuler, D., Hirschhorn, J. N., Klannemark, M., et al. (2000) The common PPARgamma Pro12Ala polymorphism is associated with
decreased risk of type 2 diabetes. Nat. Genet.
26, 76–80.
|
| |
| 15. |
Gloyn, A. L., Pearson, E. R., Antcliff, J. F., et al. (2004) Activating mutations in the gene encoding the ATP-sensitive potassium-channel
subunit Kir6.2 and permanent neonatal diabetes. N. Engl. J. Med.
350, 1838–1849.
|
| |
| 16. |
Inoue, H., Ferrer, J., Welling, C. M., et al. (1996) Sequence variants in the sulfonylurea receptor (SUR) gene are associated
with NIDDM in Caucasians. Diabetes
45, 825–831.
|
| |
| 17. |
’t Hart, L. M., De Knijff, P., Dekker, J. M., et al.(1999) Variants in the sulphonylurea receptor gene: association of the
exon 16-3t variant with type II diabetes mellitus in Dutch Caucasians. Diabetologia
42, 617–620.
|
| |
| 18. |
Rissanen, J., Markkanen, A., Kärkkäinen, P., et al. (2000) Sulfonylurea receptor 1 gene variants are associated with gestational
diabetes and type 2 diabetes but not with altered secretion of insulin. Diabetes Care
23, 70–73.
|
| |
| 19. |
Meirhaeghe, A., Helbecque, N., Cottel, D., et al. (2001) Impact of sulfonylurea receptor 1 genetic variability on non-insulin-dependent
diabetes mellitus prevalence and treatment: a population study. Am. J. Med. Genet.
101, 4–8.
|
| |
| 20. |
Hani, E. H., Clement, K., Velho, G., et al. (1997) Genetic studies of the sulfonylurea receptor gene locus in NIDDM and in
morbid obesity among French Caucasians. Diabetes
46, 688–694.
|
| |
| 21. |
Hansen, T., Echwald, S. M., Hansen, L., et al. (1998) Decreased tolbutamide-stimulated insulin secretion in healthy subjects
with sequence variants in the highaffinity sulfonylurea receptor gene. Diabetes
47, 598–605.
|
| |
| 22. |
Sakura, H., Wat, N., Horton, V., Millns, H., Turner, R. C., and Ashcroft, F. M. (1996) Sequence variations in the human Kir6.2
gene, a subunit of the beta-cell ATP-sensitive K-channel: no association with NIDDM in white Caucasian subjects or evidence
of abnormal function when expressed in vitro. Diabetologia
39, 1233–1236.
|
| |
| 23. |
Inoue, H., Ferrer, J., Warren-Perry, M., et al. (1997) Sequence variants in the pancreatic islet b-cell inwardly rectifying
K+ channel Kir6.2 (Bir) gene: identification and lack of role in caucasian patients with NIDDM. Diabetes
46, 502–507.
|
| |
| 24. |
Hani, E. H., Boutin, P., Durand, E., et al. (1998) Missense mutations in the pancreatic islet beta cell inwardly rectifying
K+channel gene (KIR6.2/BIR): a meta-analysis suggests a role in the polygenic basis of type II diabetes mellitus in Caucasians. Diabetologia
41, 1511–1515.
|
| |
| 25. |
Gloyn, A. L., Weedon M. N., Owen, K. R., et al. (2003) Large scale association studies of variants in genes encoding the pancreatic
beta-cell K-ATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with
increased risk of type 2 diabetes. Diabetes
52, 568–572.
|
| |
| 26. |
Barroso, I., Luan, J., Middelberg, R. P., et al. (2003) Candidate gene association study in type 2 diabetes indicates a role
for genes involved in beta-cell function as well as insulin action. PLoS Biol.
1, E20.
|
| |
| 27. |
Florez, J. C., Burtt, N., de Bakker, P. I., et al. (2004) Haplotype structure and genotype-phenotype correlations of the sulfonylurea
receptor and the islet ATP-sensitive potassium channel gene region. Diabetes
53, 1360–1368.
|
| |
| 28. |
Nielsen, E. D., Hansen, L., Carstensen, B., et al. (2003). The E23K variant of Kir6.2 associates with impaired post-OGTT serum
insulin response and increased risk of type 2 diabetes. Diabetes
52, 573–577.
|
| |
| 29. |
Love-Gregory, L., Wasson, K., Lin, J., Skolnick, G., Suarez, B., and Permutt, M. A. (2002) An E23K single nucleotide polymorphism
in the islet ATP-sensitive potassium channel gene (Kir6.2) contributes as much to the risk of type II diabetes in Caucasians
as the PPAR? Pro12Ala variant. Diabetologia
45, 136–137.
|
| |
| 30. |
van Dam, R. M., Hoebee, B., Seidell, J. C., Schaap, M. M., de Bruin, T. W., and Feskens, E. J. (2005) Common variants in the
ATP-sensitive K+ channel genes KCNJ11 (Kir6.2) and ABCC8 (SUR1) in relation to glucose intolerance: population-based studies
and meta-analyses. Diabet Med.
22, 590–598.
|
| |
| 31. |
Schwanstecher, C., Neugebauer, B., Schulz, M., and Schwanstecher, M. (2002) The common single nucleotide polymorphism E23K
in KIR6.2 sensitizes pancreatic β-cell ATP-sensitive potassium channels toward activation through nucleoside diphosphonates.
Diabetes
51, S363–S367.
|
| |
| 32. |
The International HapMap Consortium. (2005) A haplotype map of the human genome. Nature
437, 1299–1320.
|
| |
| 33. |
Carlson, C. S., Eberle, M. A., Rieder, M. J., Yi, Q., Kruglyak, L., and Nickerson, D. A. (2004) Selecting a maximally informative
set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am. J. Hum. Genet.
74, 106–120.
|
| |
| 34. |
Zeggini, E., Rayner, W., Morris, A., et al. (2005) HapMap sample size and tagging SNP performance: an evaluation in large-scale
empirical and simulated data sets. Nat Genet.
37, 1320–1322.
|
| |
| 35. |
Palmer, L. J. and Cardon, L. R. (2005) Shaking the tree: mapping complex disease genes with linkage disequilibrium. Lancet
366, 1223–1234.
|
| |
| 36. |
McCarthy, M. I. (2003) Growing evidence for diabetes susceptibility genes from genome scan data. Curr. Diab. Rep.
3, 159–167.
|
| |
| 37. |
Roberts, S. B., MacLean, C. J., Neale, M. C., Eaves, L. J., and Kendler, L. S. (1999) Replication of linkage studies of complex
traits: an examination of variance in location estimates. Am. J. Hum. Genet.
65, 876–884.
|
| |
| 38. |
Gibson, F. and Froguel, P. (2004) Genetics of the APM1 locus and its contribution to type 2 diabetes susceptibility in French Caucasians. Diabetes
53, 2977–2983.
|
| |
| 39. |
Vasseur, F., Helbecque, N., Dina, C., et al. (2002) Single nucleotide polymorphism haplotypes in the both proximal promoter
and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for
type 2 diabetes in French Caucasians. Hum. Mol. Genet.
11, 2607–2614.
|
| |
| 40. |
Walder, K., Kerr-Bayles, L., Civitarese, A., et al. (2005) The mitochondrial rhomboid protease PSARL is a new candidate gene
for type 2 diabetes. Diabetologia
48, 459–468.
|
| |
| 41. |
Bowden, D. W., Sale, M., Howard, T. D., et al. (1997) Linkage of genetic markers on human chromosomes 20 and 12 to NIDDM in
Caucasian sib pairs with a history of diabetic nephropathy. Diabetes
46, 882–886.
|
| |
| 42. |
Ji, L., Malecki, M., Warram, J. H., Yang, Y., Rich, S. S., and Krolewski, A. S. (1997) New susceptibility locus for NIDDM
is localized to human chromosome 20q. Diabetes
46, 876–881.
|
| |
| 43. |
Klupa, T., Malecki, M. T., Pezzolesi, M., et al. (2000) Further evidence for a susceptibility locus for type 2 diabetes on
chromosome 20q13.1-q13.2. Diabetes
49, 2212–2216.
|
| |
| 44. |
Permutt, M. A., Wasson, J. C., Suarez, B. K., et al. (2001) A genome scan for type 2 diabetes susceptibility loci in a genetically
isolated population. Diabetes
50, 681–685.
|
| |
| 45. |
Ghosh, S., Watanabe, R. M., Hauser, E. R., et al. (1999) Type 2 diabetes: evidence for linkage on chromosome 20 in 716 Finnish
affected sib pairs. Proc. Natl. Acad. Sci. USA
96, 2198–2203.
|
| |
| 46. |
Zouali, H., Hani, E. H., Philippi, A., et al. (1997) A susceptibility locus for earlyonset non-insulin dependent (type 2)
diabetes mellitus maps to chromosome 20q, proximal to the phosphoenolpyruvate carboxykinase gene. Hum. Mol. Genet.
6, 1401–1408.
|
| |
| 47. |
Elchebly, M., Payette, P., Michaliszyn, E., et al. (1999) Increased insulin sensitivity and obesity resistance in mice lacking
the protein tyrosine phosphatase-1B gene. Science
283, 1544–1548.
|
| |
| 48. |
Klaman, L. D., Boss, O., Peroni, O. D., et al. (2000) Increased energy expenditure, decreased adiposity, and tissue-specific
insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Mol. Cell Biol.
20, 5479–5489.
|
| |
| 49. |
Echwald, S. M., Bach, H., Vestergaard, H., et al. (2002) A P387L variant in protein tyrosine phosphatase-1B (PTP-1B) is associated
with type 2 diabetes and impaired serine phosphorylation of PTP-1B in vitro. Diabetes
51, 1–6.
|
| |
| 50. |
Weng, J., Yan, J., Huang, Z., Sui, Y., and Xiu, L. (2003) Missense mutation of Pro387Leu in protein tyrosine phosphatase-1B
(PTP-1B) is not associated with type 2 diabetes in a Chinese Han population. Diabetes Care
26, 2957.
|
| |
| 51. |
Santaniemi, M., Ukkola, O., and Kesaniemi, Y. A. (2004) Tyrosine phosphatase 1B and leptin receptor genes and their interaction
in type 2 diabetes. J. Intern. Med.
256, 48–55.
|
| |
| 52. |
Dahlman, I., Wahrenberg, H., Persson, L., and Arner, P. (2004) No association of reported functional protein tyrosine phosphatase
1B 3′ UTR gene polymorphism with features of the metabolic syndrome in a Swedish population. J. Intern. Med.
255, 694–695.
|
| |
| 53. |
Bento, J. L., Palmer, N. D., Mychaleckyj, J. C., et al. (2004) Association of protein tyrosine phosphatase 1B gene polymorphisms
with type 2 diabetes. Diabetes
53, 3007–3012.
|
| |
| 54. |
Palmer, N. D., Bento, J. L., Mychaleckyj, J. C., et al. (2004) Association of protein tyrosine phosphatase 1B gene polymorphisms
with measures of glucose homeostasis in Hispanic Americans: the insulin resistance atherosclerosis study (IRAS) family study.
Diabetes
53, 3013–3019.
|
| |
| 55. |
Florez, J. C., Agapakis, C. M., Burtt, N. P., et al. (2005) Association testing of the protein tyrosine phosphatase 1B gene
(PTPN1) with type 2 diabetes in 7,883 people. Diabetes
54, 1884–1891.
|
| |
| 56. |
Neale, B. M. and Sham, P. C. (2004) The future of association studies: gene-based analysis and replication. Am. J. Hum. Genet.
75, 353–362.
|
| |
| 57. |
Dermitzakis, E. T., Reymond, A., and Antonarakis, S. E. (2005) Conserved nongenic sequences-an unexpected feature of mammalian
genomes. Nat. Rev. Genet.
6, 151–157.
|
| |
| 58. |
Fingerlin, T. L., Boehnke, M., and Abecasis, G. R. (2004) Increasing the power and efficiency of disease-marker case-control
association studies through use of allelesharing information. Am. J. Hum. Genet.
74, 432–443.
|
| |
| 59. |
Hanis, C. L., Boerwinkle, E., Chakraborty, R., et al. (1996) A genome-wide search for human non-insulin-dependent (type 2)
diabetes genes reveals a major susceptibility locus on chromosome 2. Nat. Genet.
13, 161–171.
|
| |
| 60. |
Horikawa, Y., Oda, N., Cox, N. J., et al. (2000) Genetic variation in the gene encoding calpain-10 is associated with type
2 diabetes mellitus. Nat. Genet.
26, 163–175.
|
| |
| 61. |
Baier, L. J., Permana, P. A., Yang, X., et al. (2000) A calpain-10 gene polymorphism is associated with reduced muscle mRNA
levels and insulin resistance. J. Clin. Invest.
106, R69–R73.
|
| |
| 62. |
Cassell, P. G., Jackson, A. E., North, B. V., et al. (2002) Haplotype combinations of calpain 10 gene polymorphisms associate
with increased risk of impaired glucose tolerance and type 2 diabetes in South Indians. Diabetes
51, 1622–1628.
|
| |
| 63. |
Garant, M. J., Kao, W. H., Brancati, F., et al. (2002) Atherosclerosis Risk in Communities Study. SNP43 of CAPN10 and the
risk of type 2 diabetes in African-Americans: the Atherosclerosis Risk in Communities Study. Diabetes
51, 231–237.
|
| |
| 64. |
Malecki, M. T., Moczulski, D. K., Klupa, T., et al. (2002) Homozygous combination of calpain 10 gene haplotypes is associated
with type 2 diabetes mellitus in a Polish population. Eur. J. Endocrinol.
146, 695–699.
|
| |
| 65. |
Orho-Melander, M., Klannemark, M., Svensson, M. K., Ridderstrale, M., Lindgren, C. M., and Groop, L. (2002) Variants in the
calpain-10 gene predispose to insulin resistance and elevated free fatty acid levels. Diabetes
51, 2658–2664.
|
| |
| 66. |
Evans, J. C., Frayling, T. M., Cassell, P. G., et al. (2001) Studies of association between the gene for calpain-10 and type
2 diabetes mellitus in the United Kingdom. Am. J. Hum. Genet.
69, 544–552.
|
| |
| 67. |
Fingerlin, T. E., Erdos, M. R., Watanabe, R. M., et al. (2002) Variation in three single nucleotide polymorphisms in the calpain-10
gene not associated with type 2 diabetes in a large Finnish cohort. Diabetes
51, 1644–1648.
|
| |
| 68. |
Hegele, R. A., Harris, S. B., Zinman, B., Hanley, A. J., and Cao, H. (2001) Absence of association of type 2 diabetes with
CAPN10 and PC-1 polymorphisms in Oji-Cree. Diabetes Care
24, 1498–1499.
|
| |
| 69. |
Tsai, H. J., Sun, G., Weeks, D. E., et al. (2001) Type 2 diabetes and three calpain-10 gene polymorphisms in Samoans: no evidence
of association. Am. J. Hum. Genet.
69, 1236–1244.
|
| |
| 70. |
Xiang, K., Fang, Q., Zheng, T., et al. (2001) The impact of calpain-10 gene combined-SNP variation on type 2 diabetes mellitus
and its related metabolic traits. Zhonghua Yi Xue Yi Chuan Xue Za Zhi.
18, 426–430.
|
| |
| 71. |
Daimon, M., Oizumi, T., Saitoh, T., et al. (2002) Calpain 10 gene polymorphisms are related, not to type 2 diabetes, but to
increased serum cholesterol in Japanese. Diabetes Res. Clin. Pract.
56, 147–152.
|
| |
| 72. |
Elbein, S. C., Chu, W., Ren, Q., et al. (2002) Role of calpain-10 gene variants in familial type 2 diabetes in Caucasians.
J. Clin. Endocrinol. Metab.
87, 650–654.
|
| |
| 73. |
Rasmussen, S. K., Urhammer, S. A., Berglund, L., et al. (2002) Variants within the calpain-10 gene on chromosome 2q37 (NIDDM1)
and relationships to type 2 diabetes, insulin resistance, and impaired acute insulin secretion among Scandinavian Caucasians.
Diabetes
51, 3561–3567.
|
| |
| 74. |
Horikawa, Y., Oda, N., Yu, L., et al. (2003) Genetic variations in calpain-10 gene are not a major factor in the occurrence
of type 2 diabetes in Japanese. J. Clin. Endocrinol. Metab.
88, 244–247.
 |